Table 2 Presenting symptoms, signs, symptom duration, vertebral column involvement, pathogenic mycobacteria, and antibiotic sensitivities of patients with spinal tuberculosis.
| Number | Presenting symptoms | Presenting signs | Const Symt | Duration of symptoms (months) | Vertebral column involvement | Culture | Sensitivity | ||
|---|---|---|---|---|---|---|---|---|---|
| Msk | Neuro | Msk | Neuro | ||||||
| 1 | Y | Y | 23 | T8–T9 | Neg | – | |||
| 2 | Y | Y | Y | Y | 30 | T2–T3 | MTB | S resistant | |
| 3 | Y | 12 | L2–L3 | MTB | FS | ||||
| 4 | Y | Y | Y | Y | 2 | T5–T8 | MTB | FS | |
| 5 | Y | Y | Y | Y | 6 | T10–T11 | Neg | – | |
| 6 | Y | Y | Y | 1.5 | L4–L5 | Neg | – | ||
| 7 | Y | Y | 3 | T4–T5 | Neg | – | |||
| 8 | Y | Y | 12 | N/A | MTB | S resistant | |||
| 9 | Y | Y | Y | 5 | T5–T6 | MTB | FS | ||
| 10 | Y | T12–L1 | MTB | FS | |||||
| 11 | Y | Y | 3 | T9–T12 | MTB | S resistant | |||
| 12 | Y | Y | 2 | S1 | MTB | FS | |||
| 13 | Y | 6 | T7, L2–L3 | Neg | – | ||||
| 14 | Y | Y | Y | 36 | T10–L1 | MTB | FS | ||
| 15 | Y | 5 | T11–T12, L3–L5 | MTB | FS | ||||
| 16 | Y | Y | Y | 3 | T10 | MTB | FS | ||
| 17 | Y | Y | 7 | T10–T11 | MTB | INH resistant | |||
| 18 | Y | Y | 27 | C1–C4 | MTB | FS | |||
| 19 | Y | Y | 6 | T8 | MTB | FS | |||
| 20 | Y | Y | 6 | C1–C2, T3, L3 | MTB (MDR) | R, INH, Z, ETH, S,Cip, resistant | |||
| 21 | Y | Y | N | Y | Y | 18 | T10–12 | MTB | FS |
Msk, musculoskeletal; neuro, neurological; Y, yes; C, cervical; T, thoracic; L, lumbar; MTB, mycobacterium tuberculosis; MDR, multiple drug resistant; FS, fully sensitive; S, streptomycin; INH, isoniazid; R, rifampicin; Z, pyrazinamide; ETH, ethambutol; Cip, ciprofloxacin; Const Symt, constitutional symptoms; N/A, not available.